PROCEPT BioRobotics (PRCT) - 2024 Q2 - Quarterly Results

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance SAN JOSE, Calif., August 1, 2024 -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended June 30, 2024. Recent Highlights • Total revenue of $53.4 million for the second quarter of 2024, an increase of 61% com ...